BlackRock’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-482,645
| Closed | -$965K | – | 5709 |
|
2022
Q3 | $965K | Sell |
482,645
-14,630
| -3% | -$29.3K | ﹤0.01% | 4400 |
|
2022
Q2 | $1.34M | Sell |
497,275
-7,133
| -1% | -$19.3K | ﹤0.01% | 4325 |
|
2022
Q1 | $1.7M | Buy |
504,408
+108,335
| +27% | +$364K | ﹤0.01% | 4373 |
|
2021
Q4 | $1.81M | Buy |
+396,073
| New | +$1.81M | ﹤0.01% | 4375 |
|